Geode Capital Management’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.48M | Sell |
|
|||||
|
2025
Q1 | $378K | Buy |
|
|||||
|
2024
Q4 | $496K | Sell |
|
|||||
|
2024
Q3 | $645K | Sell |
|
|||||
|
2024
Q2 | $640K | Buy |
|
|||||
|
2024
Q1 | $808K | Buy |
|
|||||
|
2023
Q4 | $607K | Hold |
|
|||||
|
2023
Q3 | $500K | Buy |
|
|||||
|
2023
Q2 | $567K | Buy |
|
|||||
|
2023
Q1 | $490K | Buy |
|
|||||
|
2022
Q4 | $445K | Sell |
|
|||||
|
2022
Q3 | $580K | Hold |
|
|||||
|
2022
Q2 | $215K | Sell |
|
|||||
|
2022
Q1 | $4.1M | Buy |
|
|||||
|
2021
Q4 | $7.32M | Buy |
|
|||||
|
2021
Q3 | $8.19M | Buy |
|
|||||
|
2021
Q2 | $5.78M | Buy |
|
|||||
|
2021
Q1 | $5.35M | Buy |
|
|||||
|
2020
Q4 | $6.94M | Buy |
|
|||||
|
2020
Q3 | $2.23M | Buy |
|
|||||
|
2020
Q2 | $2.66M | Buy |
|
|||||
|
2020
Q1 | $1.25M | Buy |
|
|||||
|
2019
Q4 | $1.15M | Buy |
|
|||||
|
2019
Q3 | $1.24M | Buy |
|
|||||
|
2019
Q2 | $1.32M | Buy |
|
|||||
|
2019
Q1 | $1.21M | Buy |
|
|||||
|
2018
Q4 | $564K | Buy |
|
|||||
|
2018
Q3 | $924K | Buy |
|
|||||
|
2018
Q2 | $784K | Buy |
|
|||||
|
2018
Q1 | $290K | Buy |
|